Jim Simons acquired 16 Thousand Synaptogenix shares worth $76.2 Thousand. That's 0.00% of their equity portfolio (3125th largest holding). The investor owns 1.30% of the outstanding Synaptogenix stock. The first Synaptogenix trade was made in Q3 2021. Since then Jim Simons bought shares five more times and sold shares on four occasions. The stake costed the investor $7.47 Thousand, netting the investor a gain of 920% so far.